Federal Register Notice: FDA is reopening until 4/29/16 the comment period for the notice of public meeting that appeared in the 5/13 Federal Register. In the notice, FDA invited public comment as the agency begins the process to reauthorize the Prescription Drug User Fee Act in fiscal years 2018 to 2022. To view this notice, click here.
